Published in Cancer Weekly, December 30th, 2003
This assay is the first "repeat-free" BCR/ABL four color fluorescent in situ hybridization (F-FISH) probe and it is CGI's first product to be introduced into the United States.
This F-FISH platform is used to simultaneously detect the t(9;22)(q34.1;q11.2) translocations, associated deletions, variants, and amplifications which occur in CML. The assay design improves sensitivity and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.